文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Case report: Variability in clinical features as a potential pitfall for the diagnosis of Barth syndrome.

作者信息

Tovaglieri Nicola, Russo Silvia, Micaglio Emanuele, Corcelli Angela, Lobasso Simona

机构信息

Department of Pediatrics, Niguarda Hospital, Milan, Italy.

Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.

出版信息

Front Pediatr. 2023 Aug 16;11:1250772. doi: 10.3389/fped.2023.1250772. eCollection 2023.


DOI:10.3389/fped.2023.1250772
PMID:37654687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10467424/
Abstract

BACKGROUND: Barth syndrome is a rare genetic disease characterized by cardiomyopathy, skeletal muscle weakness, neutropenia, growth retardation and organic aciduria. This variable phenotype is caused by pathogenic hemizygous variants of the gene on the X chromosome, which impair metabolism of the mitochondrial phospholipid cardiolipin. Although most patients are usually diagnosed in the first years of life, the extremely variable clinical picture and the wide range of clinical presentations may both delay diagnosis. This is the case reported here of a man affected with severe neutropenia, who was not diagnosed with Barth syndrome until adulthood. CASE PRESENTATION: We describe herein a family case, specifically two Caucasian male cousins sharing the same mutation in the gene with a wide phenotypic variability: an infant who was early diagnosed with Barth syndrome due to heart failure, and his maternal cousin with milder and extremely different clinical features who has received the same diagnosis only at 33 years of age. CONCLUSIONS: Our report supports the underestimation of the prevalence of Barth syndrome, which should be always considered in the differential diagnosis of male patients with recurrent neutropenia with or without signs and symptoms of cardiomyopathy.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a8/10467424/107c3716d959/fped-11-1250772-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a8/10467424/107c3716d959/fped-11-1250772-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a8/10467424/107c3716d959/fped-11-1250772-g001.jpg

相似文献

[1]
Case report: Variability in clinical features as a potential pitfall for the diagnosis of Barth syndrome.

Front Pediatr. 2023-8-16

[2]
Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.

Mol Genet Metab. 2012-9-18

[3]
Case Report: A Chinese child with Barth syndrome caused by a novel mutation.

Front Cardiovasc Med. 2024-9-6

[4]
Clinical presentation and natural history of Barth Syndrome: An overview.

J Inherit Metab Dis. 2022-1

[5]
Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Mol Cell Biochem. 2021-3

[6]
Late diagnosis of Barth syndrome in a 39-year-old patient with non-compaction cardiomyopathy and neutropenia.

ESC Heart Fail. 2020-4

[7]
Barth syndrome.

Orphanet J Rare Dis. 2013-2-12

[8]
Experimental models of Barth syndrome.

J Inherit Metab Dis. 2022-1

[9]
Cardiac and clinical phenotype in Barth syndrome.

Pediatrics. 2006-8

[10]
Prenatal case report of Barth syndrome caused by novel mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites.

Front Pediatr. 2022-11-9

引用本文的文献

[1]
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathy.

Sci Rep. 2025-7-2

[2]
Tafazzin-Deficient Zebrafish Display Mitochondrial Dysfunction, Neutropenia, and Metabolic Defects Without Myopathy.

Res Sq. 2025-4-24

[3]
Barth Syndrome: Gene, Cardiologic Aspects, and Mitochondrial Studies-A Comprehensive Narrative Review.

Genes (Basel). 2025-4-18

[4]
Case Report: A Chinese child with Barth syndrome caused by a novel mutation.

Front Cardiovasc Med. 2024-9-6

[5]
SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.

Sci Rep. 2024-6-13

本文引用的文献

[1]
A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.

Mol Genet Genomic Med. 2023-7

[2]
Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome.

Hum Mol Genet. 2023-6-5

[3]
Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.

Sci Rep. 2022-11-18

[4]
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome.

J Vis Exp. 2022-3-23

[5]
Case report of Barth syndrome: a forgotten cause of cardiomyopathy.

Eur Heart J Case Rep. 2021-7-5

[6]
An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.

J Inherit Metab Dis. 2022-1

[7]
Clinical presentation and natural history of Barth Syndrome: An overview.

J Inherit Metab Dis. 2022-1

[8]
Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Mol Cell Biochem. 2021-3

[9]
The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.

J Mol Biol. 2020-8-21

[10]
Late diagnosis of Barth syndrome in a 39-year-old patient with non-compaction cardiomyopathy and neutropenia.

ESC Heart Fail. 2020-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索